A small pharmaceutical company based in Canada is developing an immunosuppressant for the treatment of lupus nephritis. This company is conducting a study to demonstrate its efficacy and safety when taken orally twice daily when compared to a placebo. The duration of the study is about twelve months and consists of about 13 visits to the study clinic for that twelve month duration.
As a volunteer, you may or may not benefit from taking the study drug, but you will be contributing to research that may well help those suffering from lupus nephritis in the future. Volunteers will also have more tests and clinic assessments through the study than they would normally have in the course of their treatment, which may allow their own doctors to more thoroughly assess their condition.
There are a dozen clinical sites participating in the study located in the United States. The website linked below will give you more information and tell you how far away the closest clinic to you is.
For more information about the study click here!